With more than 40 years of experience in normal human cells and best-in-class cGMP compliance, Lonza Walkersville, Inc. is the industry leader in development, manufacturing and testing services for cell-based therapeutics. Our R&D organization has a wide range of expertise in technology and media development.

Our process development scientists partner with our clients to develop client-specific custom protocols.  We meet each unique need, encompassing every aspect of the business from raw material requirements, process flow, scalability, closed systems, automated vialing, to storage and distribution.

In May 2017, we announced investments into exosome technologies for new generation life science applications. To find out more about this exciting field, read an interview of Dr. Behzad Mahdavi, VP Strategic Innovation and Alliances for Lonza:  Lonza's New Investments in Exosome Technologies Reflect Growing Industry Interest.

Please contact us at celltherapy@lonza.com for further information or requests.